saffron

Saffron is recommended for breast cancer

Saffron (Crocus sativus L.) contains chemical constituents that are responsible for its color, flavor and aroma. Saffron contains numerous phytoactive components, including crocetin, various crocins (such as picrocrocin), kaempferol, beta-carotene, lycopene, zeaxanthin, and safranal (the main component of saffron's fragrant essential oil). Saffron components have been shown to have strong antioxidant, anti-inflammatory, cytotoxic, anti-carcinogenic and anti-tumor properties, as well as reducing blood pressure, anxiety and depression.

Both saffron and crocin have been found to suppress DNA damage in a dose dependent manner in the livers, lungs, kidneys, and spleens of laboratory mice. Saffron has been shown to inhibit carcinogen-induced skin carcinoma in mice and to have cytotoxic action against human leukemia cell lines. Saffron also has been shown to cause cell death in HeLa and HepG2 liver cancer cells and TCC 5637 transitional cell carcinoma cells. Saffron extract and its constituent, crocin, have been shown to significantly inhibit the growth of colorectal cancer cells while not harming normal cells. Crocetin, a major carotenoid component of saffron, has been shown to have significant antiproliferative and proapoptic effects in pancreatic cancer cells in the laboratory and in laboratory mice. Saffron extract has been shown to have dose-dependent inhibitory effects on the proliferation of human MCF-7 and MDA-MB-231 breast cancer cells. Saffron has been found to greatly inhibit chemotherapy-induced cellular DNA damage. However, there is some evidence that saffron could be toxic at very high doses and we recommend consuming saffron as a spice and not taking saffron tablets.

Saffron is hand picked and hand processed, which is one reason for its high market price. Saffron is grown primarily in Iran, but it is also grown in Spain, Portugal, Italy, Kashmir and some parts of North Africa. Much of the Iranian production is redistributed through Spain. Saffron grown in these regions generally is grown without using pesticides. China is also beginning to produce saffron.

Meadow saffron (Colchicum autumnale), also known as wild saffron, Autumn crocus, or colchicum, is an unrelated and poisonous plant that should not be confused with saffron and is to be avoided. It can cause thirst, pain, diarrhea, weakness, vomiting, kidney failure, coma, and death from respiratory failure. Diluted fractions of meadow saffron are sometimes used in herbal remedies for gout and arthritis.

Saffron might interfere with Warfarin (coumadin) and other blood-thinning therapy since it has been shown to reduce platelet aggregation and thrombosis formation.

Tags: angiogenesis, autumnCrocus, betaCarotene, carotenoids, chemotherapy, inflammation, lycopene, middleEastern, saffron, southernEurope, zeaxanthin

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro Flavonoids, Proanthocyanidins, and Cancer Risk: A Network of Case-Control Studies From Italy Circulating Carotenoids, Mammographic Density, and Subsequent Risk of Breast Cancer Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines Crocin from Crocus Sativus Possesses Significant Anti-Proliferation Effects on Human Colorectal Cancer Cells Inhibition of breast cancer cell proliferation by style constituents of different Crocus species Subacute Toxicity of Crocus Sativus L. (Saffron) Stigma Ethanolic Extract in Rats Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-tumor agents in mice



Breast cancer resources | Selected supplements and vitamins | Privacy policy | Search | Disclaimer/about us | Free newsletter/Donate | Sitemap